Can Haemonetics cover its short-term obligations?

Its current ratio is 2.95 — current assets exceed current liabilities.

Where does Haemonetics's balance sheet data come from?

Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Haemonetics HAE Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q4 '26	Q3 '26	Q2 '26	Q1 '26	Q4 '25
Cash and cash equivalents	$245.44M-32.5%	$363.37M+22.6%	$296.43M+1.2%	$292.9M-4.5%	$306.76M-4.4%
Accounts receivable, net	$216.86M+10.8%	$195.71M-5.5%	$207.07M+3.1%	$200.75M-0.9%	$202.66M-4.4%
Inventories	$306.37M-4.6%	$321.19M-4.5%	$336.21M-6.7%	$360.53M-1.3%	$365.14M+1.5%
Total current assets	$834.88M-11.5%	$943.67M+4.9%	$899.68M-1.5%	$913.16M-2.3%	$934.98M-7.0%
Property and equipment, net	$305.76M+2.9%	$297.23M+1.6%	$292.48M+2.0%	$286.87M+1.0%	$284.05M-0.7%
Goodwill	$656.37M+8.2%	$606.83M+0.1%	$606.1M-0.2%	$607.3M+0.5%	$604.27M-0.2%
Intangible assets, net	$447.66M+8.1%	$414.25M-2.4%	$424.57M-5.4%	$448.85M-1.5%	$455.74M-0.7%
Long-term investments	——	$97.2M+552%	$14.9M—	——	$61.6M—
Total assets	$2.4B-3.8%	$2.49B+2.0%	$2.44B-0.8%	$2.46B+0.5%	$2.45B-3.2%
Accounts payable	$51.06M+4.9%	$48.69M-21.1%	$61.69M+34.1%	$46.01M-31.3%	$67M+6.4%
Deferred revenue	——	$36.6M+3.1%	$35.5M-1.4%	$36M—	——
Current portion of long-term debt	$5.02M-98.4%	$304.75M+0.1%	$304.34M+0.1%	$303.95M+0.1%	$303.56M+5,881%
Total current liabilities	$282.6M-47.7%	$539.87M-1.5%	$548.32M+3.2%	$531.41M-8.1%	$578.11M+128%
Long-term debt	$1.22B+32.6%	$919.99M0.0%	$920.39M0.0%	$920.83M0.0%	$921.23M-24.5%
Common stock	$453K-99.7%	$150M0.0%	$150M0.0%	$150M+31,020%	$482K-99.7%
Retained earnings	$279.34M-26.7%	$381.09M+13.3%	$336.32M-5.5%	$356.05M+1.1%	$352.17M-10.2%
Total stockholders' equity	$796.32M-12.6%	$911.45M+7.3%	$849.17M-3.8%	$882.3M+7.5%	$820.84M-9.5%
Total liabilities and stockholders' equity	$2.4B-3.8%	$2.49B+2.0%	$2.44B-0.8%	$2.46B+0.5%	$2.45B-3.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Haemonetics cover its short-term obligations?: Its current ratio is 2.95 — current assets exceed current liabilities.
Where does Haemonetics's balance sheet data come from?: Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.